查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1912606

血液處理和儲存設備市場（按產品類型、技術、最終用戶和分銷管道分類）—2026-2032年全球預測

Blood Processing & Storage Equipment Market by Product Type, Technology, End User, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 183 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，血液處理和儲存設備市場價值將達到 55.2 億美元，到 2026 年將成長至 58.6 億美元，到 2032 年將達到 91.5 億美元，年複合成長率為 7.48%。

關鍵市場統計數據
基準年 2025 55.2億美元
預計年份：2026年 58.6億美元
預測年份 2032 91.5億美元
複合年成長率 (%) 7.48%

從臨床、監管和技術角度來看，血液處理和儲存設備亟需成為現代輸血和醫療服務的核心基礎設施。

目前血液處理和儲存設備的現況正處於臨床需求、技術創新和監管三者交匯點。隨著細胞療法、精準輸血實踐和複雜診斷技術被整合到臨床路徑中，支持血液採集、分離、儲存和配送的設備在安全有效地提供醫療保健服務方面發揮著日益重要的作用。近年來，人們逐漸認知到，穩健的供應鏈、可靠的低溫運輸完整性和自動化處理平台能夠直接改善患者預後並幫助醫療機構控制成本。因此，從血站到醫院再到研究機構，相關人員都在優先投資於能夠減少人為操作差異、提升處理能力以及保障血液產品從採集到輸血或治療用途全程完整性的領域。

自動化、數位化可追溯性、分散式處理、永續性需求以及服務主導商業模式如何重塑血液處理和儲存運營

市場正經歷著由自動化、數位化和醫療服務模式變革所驅動的轉型，這些因素共同重塑了血液製品的採集、處理和儲存方式。自動化降低了分離和成分配製過程中的變異性，提高了可重複性，並減少了對操作人員的依賴。同時，數位化平台增強了從捐血到受體的可追溯性，有助於監管合規和不利事件調查。這些技術進步正將營運模式從純粹的集中式處理轉向混合模式，這種模式兼顧了能夠進行大批量處理的集中式設施和以照護現場和分散性為核心的床邊/區域處理單元。

評估近期關稅調整如何強化了醫療設備採購中來源多元化、在地化生產策略和採購韌性的必要性

近期關稅措施和貿易政策的變化為醫療設備（包括血液處理和儲存設備及耗材）的籌資策略帶來了新的複雜性。進口課稅和關稅調整推高了關鍵零件的到岸成本，促使採購團隊重新評估其供應商組合併考慮其他籌資策略。為此，許多相關人員正在重組其供應鏈，透過供應商多元化、認證區域製造商以及增加關鍵耗材的庫存緩衝來維持醫療服務的連續性。雖然這種以庫存為中心的應對措施有助於緩解短期中斷，但也增加了營運資金需求並加劇了倉儲能力的壓力，從而影響了營運計畫。

深入的細分市場分析揭示了產品、最終用戶、技術和分銷維度如何影響整個醫療保健領域的採購、監管和營運選擇。

細分市場的特定特徵會影響產品、終端用戶、技術和分銷管道等各個層面的需求、技術應用和商業策略。基於產品類型，分析涵蓋了血球分離設備、血袋和血袋套裝、採血管、血型鑑定試劑、血漿分離器和儲存容器。在血球分離領域，粒細胞分離、血漿分離和血小板分離之間的區別導致了處理量、一次性耗材使用量和監管要求的差異。血袋和相關套裝的配置從單袋到雙袋、三袋和四袋不等，每種配置都會影響工作流程效率、成分產量和庫存管理。採血管根據添加劑的化學成分和用途進行分類，包括用於血液凝固檢驗的檸檬酸鹽採血管、用於血液學檢測的EDTA採血管和用於血清學檢測的凝膠分離管，每種類別都有不同的儲存和處理要求。血型鑑定試劑分為ABO血型試劑、抗體篩檢試劑和Rh因子試劑，這些試劑的分類決定了檢測流程、試劑生命週期管理以及輸血服務供應鏈的重要性。血漿分離設備主要分為離心分離系統和過濾分離系統，二者的差異在於處理量、剪切力暴露程度以及對不同血漿衍生產品的適用性。儲存容器的選擇取決於穩定性要求、低溫運輸物流以及血液製品的最終用途，並根據常溫和冷藏儲存方案進行評估。

區域比較觀點：揭示監管複雜性、基礎設施成熟度和製造業政策如何影響全球設備採用和供應策略

區域趨勢對技術採納、監管時間表和供應鏈設計有顯著影響，美洲、歐洲、中東和非洲以及亞太地區呈現出截然不同的模式。在美洲，醫療保健系統傾向於優先考慮在大規模集中式設施中擴展和整合處理基礎設施，同時投資於自動化和數位化可追溯性，以支援廣泛的全國性網路。採購週期可能受到集中式合約和報銷框架的影響，這促使供應商優先考慮強大的服務網路和合規認證。同時，歐洲、中東和非洲呈現出多元化的格局，成熟的法規結構與資源受限的環境並存。這不僅催生了對高階自動化平台的需求，也催生了對能夠滿足基本安全性和可追溯性要求的、適應性強且成本低廉的解決方案的需求。該地區多司法管轄區的複雜監管環境凸顯了在地化監管專業知識和靈活產品線的價值。

產品和服務整合、臨床檢驗、監管專業知識以及可互通的數位化解決方案將如何決定該領域的競爭優勢和客戶維繫

血液處理和儲存設備領域的競爭更取決於持續的服務關係、監管信譽以及在硬體、耗材和軟體方面的創新能力，而非一次性交易。主要企業優先投資於儀器、檢驗的耗材和全生命週期服務的整合產品組合，以建立長期的營運夥伴關係。策略差異化因素包括：支援儀器性能的深度臨床檢驗數據、覆蓋範圍廣以最大限度降低停機風險的服務網路，以及符合當地監管要求的良好記錄。此外，提供靈活商業模式（例如管理服務、試劑服務和按績效付費合約）的公司，對於尋求可預測營運預算和降低資本風險的大型機構買家而言，也越來越具有吸引力。

對領導者而言，在血液處理技術領域，提升韌性、臨床價值和競爭差異化能力，是策略、營運和商業性的當務之急。

為維持競爭力及臨床相關性，產業領導者應採取多管齊下的策略，整合採購彈性、產品創新及終端用戶價值。首先，他們應優先考慮供應商多元化和選擇區域性製造合作夥伴，以降低貿易政策波動和關稅帶來的成本波動風險。同時，應結合基於情境的庫存規劃和合約機制，與供應商分擔關稅風險。其次，他們應加快對自動化和資料互通性的投資，以減少人為操作差異、增強可追溯性並滿足監管報告要求。這些投資應輔以結構化的培訓計畫和持續改善機制，以確保實現臨床效益。

我們採用混合方法檢驗研究途徑，結合關鍵相關人員訪談、監管和技術分析以及嚴格的檢驗，以提供可操作的策略見解。

我們的研究途徑結合了定性和定量方法，旨在建立一個穩健且多角度的血液處理和儲存生態系統視圖。主要研究包括對採購主管、臨床實驗室主任、輸血服務經理和醫療設備工程師進行結構化檢驗，以了解實際挑戰、實施促進因素和採購標準。此外，我們也與生產和分銷主管進行面對面交流，以了解供應鏈策略、產品藍圖和服務模式。次要研究則利用監管文件、技術標準、製造商文件和同行評審文獻，來檢驗產品性能聲明、滅菌和儲存要求以及技術規範。

整合營運、技術和策略主題，強調臨床上對整合解決方案、採購彈性以及可追溯的自動化工作流程的需求。

綜合評估顯示，血液處理和儲存設備正從通用硬體轉變為整合自動化、檢驗的耗材和數位化追蹤的臨床基礎設施。營運重點正轉向降低變異性、確保低溫運輸全程的產品完整性以及確保快速獲得備件和服務。籌資策略必須透過多元化採購管道、選擇區域供應商以及在採購合約中加入服務和保固條款來適應地緣政治和關稅壓力。技術趨勢表明，自動化和互通性將進一步發展，而細分市場的差異則表明，產品特性和最終用戶的特定需求將顯著影響產品的採用時間和價值實現。

目錄

第1章：序言

第2章調查方法

  • 研究設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查前提
  • 調查限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會地圖
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

8. 依產品類型分類的血液處理和儲存設備市場

  • 血液分離機
    • 粒細胞分離術
    • 血漿置換
    • 血小板分離術
  • 血袋和血包
    • 雙血袋
    • 單血袋
    • 三袋和四袋血袋
  • 採血管
  • 血型鑑定試劑
  • 等離子分離器
  • 儲存容器

9. 按技術分類的血液處理和儲存設備市場

  • 自動化
  • 手動的
  • 半自動

第10章 依最終用戶分類的血液處理和儲存設備市場

  • 血庫
  • 診斷檢查室
  • 醫院
  • 研究所

第11章 按分銷管道分類的血液處理和儲存設備市場

  • 直銷
  • 經銷商
  • 線上

第12章：血液處理和儲存設備市場（按地區分類）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第13章 血液處理與儲存設備市場（依組別分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章 各國血液處理及儲存設備市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章：美國血液處理與儲存設備市場

第16章 中國血液處理與儲存設備市場

第17章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • BioLife Solutions, Inc.
  • Cerus Corporation
  • Danaher Corporation
  • Fresenius Kabi AG
  • Grifols, SA
  • Haemonetics Corporation
  • PHC Holdings Corporation
  • Sebia, Inc.
  • StemCyte Inc.
  • Stirling Ultracold
  • Terumo Corporation
  • Thermo Fisher Scientific Inc.
  • ThermoGenesis Holdings, Inc.
  • Vita 34 AG
Product Code: MRR-AE420CB13A57

The Blood Processing & Storage Equipment Market was valued at USD 5.52 billion in 2025 and is projected to grow to USD 5.86 billion in 2026, with a CAGR of 7.48%, reaching USD 9.15 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 5.52 billion
Estimated Year [2026] USD 5.86 billion
Forecast Year [2032] USD 9.15 billion
CAGR (%) 7.48%

Framing the urgent clinical, regulatory, and technological drivers that make blood processing and storage equipment core infrastructure for modern transfusion and therapy delivery

The landscape of blood processing and storage equipment sits at the intersection of clinical necessity, technological innovation, and regulatory scrutiny. As clinical pathways evolve to include more cellular therapies, precision transfusion practices, and complex diagnostics, the equipment that underpins collection, separation, storage, and distribution becomes increasingly central to safe and effective care delivery. Recent years have underscored how resilient supply chains, robust cold chain integrity, and automated processing platforms contribute directly to patient outcomes and institutional cost control. Consequently, stakeholders from blood centers to hospitals and research institutes are prioritizing investments that reduce manual variability, increase throughput, and protect product integrity from collection through to transfusion or therapeutic use.

In parallel, regulatory agencies and accreditation bodies are tightening expectations around traceability, sterility, and validated storage conditions. These expectations are catalyzing a shift from legacy manual workflows toward integrated solutions that combine instrument-level automation with data capture and interoperability. The result is a market dynamic in which manufacturers must not only deliver reliable hardware but also embed software, service, and lifecycle management capabilities. For decision-makers, the imperative is clear: evaluate equipment on total cost of ownership and clinical risk reduction, prioritize vendor ecosystems that offer end-to-end support, and plan procurement cycles with a focus on modularity and future-proofing. This introduction frames the criticality of treating blood processing and storage equipment not as isolated capital purchases but as foundational infrastructure for modern transfusion and therapeutic workflows.

How automation, digital traceability, decentralized processing, sustainability imperatives, and service-led commercial models are reshaping blood handling and storage operations

The market is undergoing transformative shifts driven by automation, digitalization, and changing care delivery models that together redefine how blood products are collected, processed, and stored. Automation is reducing variability in separation and component preparation, thereby improving reproducibility and lowering operator dependence. At the same time, digital platforms are enabling richer traceability from donor to recipient, which supports both regulatory compliance and adverse event investigation. These technological advances are fostering an operational move away from purely centralized processing toward hybrid models that balance high-volume central facilities with point-of-care or regional processing units where immediacy and decentralization matter most.

Concurrently, industry stakeholders are re-evaluating single-use consumables and closed-system designs to mitigate contamination risk and streamline workflow. Sustainability considerations are prompting design changes in materials, energy use, and cold chain logistics. Strategic partnerships and service-oriented commercial models are emerging as manufacturers seek to offer lifecycle value rather than transactional sales. Finally, the growing importance of plasma-derived therapies and cellular products has elevated the role of specialized separation technologies and validated cold storage systems. Taken together, these shifts mean that buyers increasingly expect integrated solutions that blend equipment, consumables, software, and service-creating an environment where innovation, regulatory alignment, and commercial agility determine market leadership.

Assessing how recent tariff realignments have reinforced the need for supplier diversification, regional production strategies, and procurement resilience in medical device sourcing

Recent tariff actions and trade policy shifts have introduced new layers of complexity to procurement strategies for medical equipment, including machines and consumables used in blood processing and storage. Import levies and tariff realignments can elevate landed costs for key components, prompting procurement teams to re-evaluate vendor portfolios and consider alternative sourcing strategies. In response, many stakeholders are recalibrating supply chains by diversifying suppliers, qualifying regional manufacturers, and increasing inventory buffers for critical consumables to maintain continuity of care. This inventory-centric response helps mitigate short-term disruption, but it also elevates working capital requirements and stresses storage capacity, which in turn affects operational planning.

Beyond immediate procurement impacts, tariffs can influence longer-term supplier decisions and investment flows. Manufacturers may accelerate regional production or assembly to avoid tariff exposure, which can benefit local industry but requires time and capital to realize. Regulatory and quality assurance processes often slow nearshoring efforts, so organizations must weigh the benefits of reduced trade friction against the certification and validation timelines inherent in medical device manufacture. Additionally, procurement teams are increasingly incorporating tariff sensitivity analysis into tender evaluations, factoring potential duty changes into contract terms and supplier performance clauses. Overall, the cumulative effect of tariff policy shifts encourages a more resilient, diversified supply strategy that balances cost, compliance, and continuity-while underscoring the strategic value of adaptable sourcing and robust supplier partnerships.

In-depth segmentation analysis revealing how product, end-user, technology, and distribution dimensions determine procurement, regulatory, and operational choices across the care continuum

Segment-specific dynamics shape demand, technology adoption, and commercial strategy across the product, end user, technology, and distribution channel dimensions. Based on product type, analysis covers apheresis equipment, blood bags and sets, blood collection tubes, grouping reagents, plasma separation equipment, and storage containers. Within apheresis, distinctions among granulocyte apheresis, plasma apheresis, and platelet apheresis drive different throughput, disposables usage, and regulatory expectations. Blood bags and associated sets vary by configuration, from single to double to triple and quadruple systems, each influencing workflow efficiency, component yield, and inventory management. Blood collection tubes are categorized by additive chemistry and use case, including citrate tubes for coagulation studies, EDTA tubes for hematology, and gel separator tubes for serum-based testing, and each category imposes distinct storage and handling requirements. Grouping reagents span ABO, antibody screening, and Rh reagents, which together dictate testing algorithms, reagent lifecycle management, and supply chain criticality for transfusion services. Plasma separation equipment differs fundamentally across centrifuge systems and filtration systems, affecting throughput, shear exposure, and suitability for different plasma-derived products. Storage containers are evaluated across ambient and refrigerated solutions, with choice driven by stability requirements, cold chain logistics, and the intended end use of the blood product.

Based on end user, the market perspective shifts among blood banks, diagnostic laboratories, hospitals, and research institutes, each of which has unique purchasing cycles and operational priorities. Blood banks focus on component yield, donor throughput, and traceability, while diagnostic laboratories emphasize tube chemistry consistency and sample integrity for downstream testing. Hospitals require integrated solutions that align with transfusion services and patient care pathways, and research institutes often seek customizable platforms that support method development and experimental validation. Based on technology, adoption patterns between automated, manual, and semi-automated systems influence staff training requirements, throughput scalability, and error rates. Automated systems reduce operator variability and facilitate data capture, whereas manual workflows remain relevant in low-volume or resource-constrained settings; semi-automated options often serve as compromise solutions where partial mechanization yields meaningful efficiency gains. Finally, based on distribution channel, direct sales, distributors, and e-commerce channels each deliver different levels of service, contractual complexity, and local regulatory support. Direct sales can provide tight integration with clinical service teams and bespoke service agreements, while distributors offer local reach and inventory support, and e-commerce channels increase access for standardized consumables and low-complexity items. Understanding the interplay among these segmentation axes is essential to aligning product development, go-to-market strategy, and supply chain design with the needs of diverse customer archetypes.

Comparative regional perspectives showing how regulatory complexity, infrastructure maturity, and manufacturing policies shape equipment adoption and supply strategies worldwide

Regional dynamics materially influence technology adoption, regulatory timelines, and supply chain design, with distinct patterns emerging across the Americas, Europe, Middle East & Africa, and Asia-Pacific. In the Americas, healthcare systems tend to emphasize scale and consolidation of processing infrastructure in larger central facilities while also investing in automation and digital traceability to support broad national networks. Procurement cycles can be influenced by centralized contracting and reimbursement frameworks, leading suppliers to prioritize robust service networks and compliance credentials. In contrast, Europe, Middle East & Africa presents a heterogeneous picture in which mature regulatory frameworks coexist with resource-constrained settings, creating demand for both high-end automated platforms and adaptable, lower-cost solutions that meet basic safety and traceability requirements. Multi-jurisdictional regulatory complexity in this region increases the value of localized regulatory expertise and flexible product lines.

Asia-Pacific exhibits rapid adoption of both centralized and decentralized models driven by population scale, expanding healthcare infrastructure, and strategic investments in domestic manufacturing capacity. Demand patterns often emphasize cost-efficiency and scalability, while governments may support nearshoring initiatives that reduce import dependencies. Across all regions, cold chain integrity remains a universal priority, but the logistical challenges and infrastructure investments required to maintain refrigerated storage and transport vary substantially. In addition, regional variations in clinical practice patterns, blood donation rates, and therapeutic priorities shape product preferences and the relative importance of consumables versus capital equipment. For organizations operating cross-regionally, success depends on tailoring go-to-market approaches to local procurement processes, regulatory environments, and service expectations while ensuring global standards for quality and traceability are upheld.

How product-service integration, clinical validation, regulatory expertise, and interoperable digital offerings define competitive advantage and customer retention in this sector

Competitive dynamics in the blood processing and storage equipment space are defined less by one-time transactions and more by enduring service relationships, regulatory credibility, and the ability to innovate across hardware, consumables, and software. Leading organizations tend to invest in integrated portfolios that combine instruments with validated consumables and lifecycle services, thereby locking in long-term operational partnerships. Strategic differentiators include the depth of clinical validation data supporting device performance, the breadth of service networks that minimize downtime risk, and demonstrated adherence to regional regulatory requirements. Additionally, companies that offer flexible commercial models-such as managed services, reagent-as-a-service, or outcome-linked agreements-are increasingly attractive to large institutional buyers seeking predictable operational budgets and reduced capital exposure.

Collaboration between manufacturers and end users is accelerating product refinement cycles, with field feedback informing consumable design, usability improvements, and software interoperability. Firms that prioritize interoperability with hospital information systems and laboratory information management systems gain advantage in procurement evaluations that emphasize data integrity and traceability. Finally, investment in training and technical support is a critical competitive lever; vendors that can demonstrate rapid response times, strong parts availability, and deployment support for validation and change management typically maintain higher retention and referral rates among hospital transfusion services and centralized blood centers.

Strategic, operational, and commercial imperatives for leaders to enhance resilience, clinical value, and competitive differentiation in blood handling technologies

Industry leaders should adopt a multifaceted strategy that aligns procurement resilience, product innovation, and end-user value to remain competitive and clinically relevant. First, prioritize supplier diversification and qualification of regional manufacturing partners to reduce exposure to trade policy shocks and tariff-driven cost volatility. This should be paired with scenario-based inventory planning and contractual mechanisms that share tariff risk with suppliers. Second, accelerate investments in automation and data interoperability to reduce manual variability, enhance traceability, and support regulatory reporting requirements. These investments must be accompanied by structured training programs and continuous improvement pathways to ensure realized clinical benefits.

Third, reframe commercial offerings toward lifecycle value by bundling equipment with validated consumables, preventative maintenance, and outcome-based service agreements. This approach not only stabilizes revenue streams but also aligns incentives between supplier and end user around uptime and clinical performance. Fourth, embed sustainability into product design and logistics planning to reduce environmental impact and respond to institutional procurement mandates. Finally, cultivate close partnerships with clinical and laboratory stakeholders to co-develop solutions, accelerate clinical validation, and streamline regulatory submissions. Taken together, these recommendations help manufacturers and buyers reduce operational risk, improve patient safety, and unlock differentiated value in a market where clinical and regulatory demands continue to evolve rapidly.

A mixed-methods, triangulated research approach combining primary stakeholder interviews, regulatory and technical analysis, and rigorous validation to produce actionable strategic insights

The research approach combines qualitative and quantitative methods to produce a robust, triangulated view of the blood processing and storage ecosystem. Primary research includes structured interviews with procurement leaders, clinical laboratory directors, transfusion service managers, and biomedical engineers to capture real-world operational pain points, adoption drivers, and procurement criteria. These insights are complemented by direct discussions with manufacturing and distribution executives to understand supply chain strategies, product roadmaps, and service models. Secondary research draws on regulatory filings, technical standards, manufacturer documentation, and peer-reviewed literature to validate product performance claims, sterilization and storage requirements, and technology specifications.

Data were synthesized through triangulation, where field interviews were cross-checked against publicly available regulatory documentation and technical white papers to ensure consistency. Segmentation mapping was applied across product type, end user, technology, and distribution channels to ensure that insights reflect operational realities across different care settings. Quality assurance measures included expert peer review and internal validation checks to identify contradictions and ensure methodological transparency. Limitations include variability in regional data transparency and the lag between regulatory changes and their operational impact; these were mitigated by prioritizing recent primary interviews and regulatory guidance documents. The methodology emphasizes actionable insights and is designed to support both strategic decision-making and tactical procurement actions.

Synthesis of operational, technological, and strategic themes emphasizing integrated solutions, procurement resilience, and the clinical imperative for traceable, automated workflows

The cumulative assessment highlights that blood processing and storage equipment is transitioning from commodity hardware toward integrated clinical infrastructure that combines automation, validated consumables, and digital traceability. Operational priorities increasingly center on reducing variability, safeguarding product integrity across the cold chain, and ensuring rapid access to spare parts and service. Procurement strategies must adapt to geopolitical and tariff-driven pressures by diversifying sourcing, qualifying regional suppliers, and embedding service and warranty protections into purchasing agreements. Technology trends point toward greater automation and interoperability, while segmentation nuances show that product and end-user specificity materially influence adoption timelines and value realization.

For stakeholders across the ecosystem, the path forward requires coordinated investments in equipment lifecycle management, workforce training, and data systems that support regulatory traceability and clinical decision-making. Manufacturers must continue to innovate around closed-system designs, validated consumables, and software-enabled workflow optimization. End users should prioritize total cost of ownership and clinical risk reduction when evaluating new equipment. By aligning commercial models with clinical outcomes and operational resilience, the sector can deliver safer, more efficient transfusion services and support the expanding needs of plasma and cellular therapies.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Blood Processing & Storage Equipment Market, by Product Type

  • 8.1. Apheresis Equipment
    • 8.1.1. Granulocyte Apheresis
    • 8.1.2. Plasma Apheresis
    • 8.1.3. Platelet Apheresis
  • 8.2. Blood Bags & Sets
    • 8.2.1. Double Blood Bag
    • 8.2.2. Single Blood Bag
    • 8.2.3. Triple And Quadruple Blood Bags
  • 8.3. Blood Collection Tubes
  • 8.4. Grouping Reagents
  • 8.5. Plasma Separation Equipment
  • 8.6. Storage Containers

9. Blood Processing & Storage Equipment Market, by Technology

  • 9.1. Automated
  • 9.2. Manual
  • 9.3. Semi Automated

10. Blood Processing & Storage Equipment Market, by End User

  • 10.1. Blood Banks
  • 10.2. Diagnostic Laboratories
  • 10.3. Hospitals
  • 10.4. Research Institutes

11. Blood Processing & Storage Equipment Market, by Distribution Channel

  • 11.1. Direct Sales
  • 11.2. Distributors
  • 11.3. Online

12. Blood Processing & Storage Equipment Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Blood Processing & Storage Equipment Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Blood Processing & Storage Equipment Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Blood Processing & Storage Equipment Market

16. China Blood Processing & Storage Equipment Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. BioLife Solutions, Inc.
  • 17.6. Cerus Corporation
  • 17.7. Danaher Corporation
  • 17.8. Fresenius Kabi AG
  • 17.9. Grifols, S.A.
  • 17.10. Haemonetics Corporation
  • 17.11. PHC Holdings Corporation
  • 17.12. Sebia, Inc.
  • 17.13. StemCyte Inc.
  • 17.14. Stirling Ultracold
  • 17.15. Terumo Corporation
  • 17.16. Thermo Fisher Scientific Inc.
  • 17.17. ThermoGenesis Holdings, Inc.
  • 17.18. Vita 34 AG

LIST OF FIGURES

  • FIGURE 1. GLOBAL BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL BLOOD PROCESSING & STORAGE EQUIPMENT MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY APHERESIS EQUIPMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY APHERESIS EQUIPMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY APHERESIS EQUIPMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY APHERESIS EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY GRANULOCYTE APHERESIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY GRANULOCYTE APHERESIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY GRANULOCYTE APHERESIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY PLASMA APHERESIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY PLASMA APHERESIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY PLASMA APHERESIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY PLATELET APHERESIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY PLATELET APHERESIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY PLATELET APHERESIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY BLOOD BAGS & SETS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY BLOOD BAGS & SETS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY BLOOD BAGS & SETS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY BLOOD BAGS & SETS, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY DOUBLE BLOOD BAG, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY DOUBLE BLOOD BAG, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY DOUBLE BLOOD BAG, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY SINGLE BLOOD BAG, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY SINGLE BLOOD BAG, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY SINGLE BLOOD BAG, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY TRIPLE AND QUADRUPLE BLOOD BAGS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY TRIPLE AND QUADRUPLE BLOOD BAGS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY TRIPLE AND QUADRUPLE BLOOD BAGS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY BLOOD COLLECTION TUBES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY BLOOD COLLECTION TUBES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY BLOOD COLLECTION TUBES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY GROUPING REAGENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY GROUPING REAGENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY GROUPING REAGENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY PLASMA SEPARATION EQUIPMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY PLASMA SEPARATION EQUIPMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY PLASMA SEPARATION EQUIPMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY STORAGE CONTAINERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY STORAGE CONTAINERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY STORAGE CONTAINERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY AUTOMATED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY AUTOMATED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY AUTOMATED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY MANUAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY MANUAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY MANUAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY SEMI AUTOMATED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY SEMI AUTOMATED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY SEMI AUTOMATED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY BLOOD BANKS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY BLOOD BANKS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY BLOOD BANKS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY DISTRIBUTORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY DISTRIBUTORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY ONLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY ONLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY ONLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. AMERICAS BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 76. AMERICAS BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 77. AMERICAS BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY APHERESIS EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 78. AMERICAS BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY BLOOD BAGS & SETS, 2018-2032 (USD MILLION)
  • TABLE 79. AMERICAS BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 80. AMERICAS BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 81. AMERICAS BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 82. NORTH AMERICA BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 83. NORTH AMERICA BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 84. NORTH AMERICA BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY APHERESIS EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 85. NORTH AMERICA BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY BLOOD BAGS & SETS, 2018-2032 (USD MILLION)
  • TABLE 86. NORTH AMERICA BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 87. NORTH AMERICA BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 88. NORTH AMERICA BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 89. LATIN AMERICA BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. LATIN AMERICA BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 91. LATIN AMERICA BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY APHERESIS EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 92. LATIN AMERICA BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY BLOOD BAGS & SETS, 2018-2032 (USD MILLION)
  • TABLE 93. LATIN AMERICA BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 94. LATIN AMERICA BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 95. LATIN AMERICA BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 96. EUROPE, MIDDLE EAST & AFRICA BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 97. EUROPE, MIDDLE EAST & AFRICA BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 98. EUROPE, MIDDLE EAST & AFRICA BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY APHERESIS EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 99. EUROPE, MIDDLE EAST & AFRICA BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY BLOOD BAGS & SETS, 2018-2032 (USD MILLION)
  • TABLE 100. EUROPE, MIDDLE EAST & AFRICA BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 101. EUROPE, MIDDLE EAST & AFRICA BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 103. EUROPE BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 104. EUROPE BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 105. EUROPE BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY APHERESIS EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 106. EUROPE BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY BLOOD BAGS & SETS, 2018-2032 (USD MILLION)
  • TABLE 107. EUROPE BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 108. EUROPE BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 109. EUROPE BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 110. MIDDLE EAST BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 111. MIDDLE EAST BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 112. MIDDLE EAST BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY APHERESIS EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 113. MIDDLE EAST BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY BLOOD BAGS & SETS, 2018-2032 (USD MILLION)
  • TABLE 114. MIDDLE EAST BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 115. MIDDLE EAST BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 116. MIDDLE EAST BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 117. AFRICA BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 118. AFRICA BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 119. AFRICA BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY APHERESIS EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 120. AFRICA BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY BLOOD BAGS & SETS, 2018-2032 (USD MILLION)
  • TABLE 121. AFRICA BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 122. AFRICA BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 123. AFRICA BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 124. ASIA-PACIFIC BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 125. ASIA-PACIFIC BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 126. ASIA-PACIFIC BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY APHERESIS EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 127. ASIA-PACIFIC BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY BLOOD BAGS & SETS, 2018-2032 (USD MILLION)
  • TABLE 128. ASIA-PACIFIC BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 129. ASIA-PACIFIC BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 130. ASIA-PACIFIC BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 131. GLOBAL BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 132. ASEAN BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 133. ASEAN BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 134. ASEAN BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY APHERESIS EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 135. ASEAN BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY BLOOD BAGS & SETS, 2018-2032 (USD MILLION)
  • TABLE 136. ASEAN BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 137. ASEAN BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 138. ASEAN BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 139. GCC BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 140. GCC BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 141. GCC BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY APHERESIS EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 142. GCC BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY BLOOD BAGS & SETS, 2018-2032 (USD MILLION)
  • TABLE 143. GCC BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 144. GCC BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 145. GCC BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 146. EUROPEAN UNION BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 147. EUROPEAN UNION BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 148. EUROPEAN UNION BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY APHERESIS EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 149. EUROPEAN UNION BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY BLOOD BAGS & SETS, 2018-2032 (USD MILLION)
  • TABLE 150. EUROPEAN UNION BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 151. EUROPEAN UNION BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 152. EUROPEAN UNION BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 153. BRICS BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 154. BRICS BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 155. BRICS BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY APHERESIS EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 156. BRICS BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY BLOOD BAGS & SETS, 2018-2032 (USD MILLION)
  • TABLE 157. BRICS BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 158. BRICS BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 159. BRICS BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 160. G7 BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 161. G7 BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 162. G7 BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY APHERESIS EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 163. G7 BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY BLOOD BAGS & SETS, 2018-2032 (USD MILLION)
  • TABLE 164. G7 BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 165. G7 BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 166. G7 BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 167. NATO BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 168. NATO BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 169. NATO BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY APHERESIS EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 170. NATO BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY BLOOD BAGS & SETS, 2018-2032 (USD MILLION)
  • TABLE 171. NATO BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 172. NATO BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 173. NATO BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 174. GLOBAL BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 175. UNITED STATES BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 176. UNITED STATES BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 177. UNITED STATES BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY APHERESIS EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 178. UNITED STATES BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY BLOOD BAGS & SETS, 2018-2032 (USD MILLION)
  • TABLE 179. UNITED STATES BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 180. UNITED STATES BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 181. UNITED STATES BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 182. CHINA BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 183. CHINA BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 184. CHINA BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY APHERESIS EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 185. CHINA BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY BLOOD BAGS & SETS, 2018-2032 (USD MILLION)
  • TABLE 186. CHINA BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 187. CHINA BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 188. CHINA BLOOD PROCESSING & STORAGE EQUIPMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)